Abstract
Primary gout has been related to obesity, gluttony and alcoholic beverages abuse (1, 2). The decreased incidence of gout during periods of poverty (First and Second World Wars) supports the theory that favours overindulgence as a precipitating cause of gout. Purine-restricted diets have been shown to diminish serum urate concentrations and urinary uric acid excretion by 0.6–2.0 mg/d1 and 200–400 mg/24 h, respectively (3–5). This fact has led most authorities to recommend a purine-restricted diet as a cornerstone in the treatment of gout. Furthermore, primary gout is frequently associated with other disturbances requiring dietary restrictions, namely: obesity (6–13), arterial hypertension (7, 11, 13–16), hyper-lipidaemia (9, 13, 17–20) and diabetes mellitus (21). However, long-term patient compliance with purine-restricted diets may be difficult, especially in patients with a chronic disease who enjoy purine-rich food and alcoholic beverages.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J.B. Wyngaarden, and W.N. Kelley. Gout, In: “The Metabolic Basis of Inherited Diseases”, J.B. Stanbury, J.B. Wyngaarden, D.S. Frederickson J.L. Goldstein, and M.S. Brown, eds., McGraw-Hill, New York, (1983).
T. Gibson, A.V. Rodgers, H.A. Simmonds, et al. A controlled study of diet in patients with gout. Ann Rheum Dis 42: 123–127 (1983).
J.E. Seegmiller, A.I. Grayzel, L. Laster, and L. Liddle. Uric acid production in gout. J Clin Invest 40: 1304–1314 (1961).
W. Stafford, and B.T. Emmerson. Effect of purine restriction on serum and urine urate in normal subjects. Adv Exp Med Biol 165A: 309–316 (1984).
W. Löffler, and W. Gröbner. A study of dose-response relationships of allopurinol in the presence of low or high purine turnover. Klin Woschenschr 66: 153–159 (1988).
A.R. Myers, F.H. Epstein, H.J. Dodge, and W.M. Mikkelsen. The relationship of serum uric acid to risk factors in coronary heart disease. Am J Med 45: 520–528 (1968).
R. Klein, B.E. Klein, J.C. Cornoni, et al. Serum uric acid. Its relationship to coronary heart disease, risk factors and cardiovascular disease, Evans County, Georgia. Arch Intern Med 132: 401–410 (1973).
L.M. Hagerup. Coronary heart disease risk factors in men and women. From the population study in Glostrup, Denmark. Acta Med Scand 557 (Suppl): 52–55 (1973).
J. Zalokar, J. Lellouch, J.R. Claude, and D. Kuntz. Epidemiology of serum uric acid and gout in Frenchmen. J Chron Dis 27: 59–75 (1974).
P. Beighton, L. Solomon, C.L. Soskolne, B. Sweet, and G. Robin. Serum uric acid concentrations in an urbanized South African Negro population. Ann Rheum Dis 33: 442–445 (1974).
R. Grahame, and J.T. Scott. Clinical survey of 354 patients with gout. Ann Rheum Dis 29: 461–468 (1970).
A.P. Hall, P.E. Barry, T.R. Pawber, and P.M. McNamara. Epidemiology of gout and hyperuricemia. A long-term population study. Am J Med 42: 27–37 (1967).
K. Yano, G.G. Rhoads, and A. Kagan. Epidemiology of serum uric acid among 8000 Japanese-American men in Hawaii. J. Chron Dis 30: 171–184 (1977).
P.J. Cannon, W.B. Stason, F. E. Pemartini, et al. Hyperuricemia in primary and renal hypertension. N Eng J Med 275: 457–464 (1966).
R. Garrick, G.E. Bauer, C.E. Ewan, and F.C. Neale. Serum uric acid in normal and hypertensive Australian subjects. Aust NZ J Med 4: 351–356 (1972).
S.L. Wallace. Gout and hypertension. Arthritis Rheum 18 (Suppl): 721–723 (1975).
L.G. Parlington, and J.T. Scott. Plasma lipid levels in gout. Ann Rheum Dis 31: 487–489 (1972).
H. Mielants, E.M. Veys, and A. De Weerdt. Gout and its relation to lipid metabolism. I. Serum uric acid and lipoprotein levels in gout. II. Correlations between uric acid, lipid and lipoprotein levels in gout. Ann Rheum Dis 32: 501–509 (1973).
T. Gibson, and R. Grahame. Gout and hyperlipidemia. Ann Rheum Dis 33: 298–303 (1974).
K.A. Barlow. Hyperlipidemia in primary gout. Metabolism 17: 289–299 (1968).
H.S. Piamond, A.C. Carter, and E.B. Feldman. Abnormal regulation of carbohydrate metabolism in primary gout. Ann Rheum Dis 34: 554–562 (1974).
S.L. Wallace, H. Robinson, A.T. Masi, J.L. Pecker, P.J. McCarty, and T-F. Yü. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20: 895–900 (1977).
G.A. Bray, H.A. Jordan, and E.A.H. Sims. Evaluation of the obese patient. 1. An algorithm. J Am Med Ass 235: 1487–1491 (1976).
E.J. Schaefer, and R.I. Levy. Pathogenesis and management of lipoprotein disorders. N Eng J Med 312: 1300–1310 (1985).
National Piabetes Pata Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Piabetes 28: 1039-1057 (1979).
N. Kageyama. A direct colorimetric determination of uric acid in serum and urine with uricase-catalase system. Clin Chim Acta 31: 421–426 (1971).
A.W. Wahlefeld, G. Holz, and H.U. Bergmeyer. Creatinine. In: “Methods of Enzymatic Analysis”, H.U. Bergmeyer, ed., Academic Press, New York, 4: 1786–1790 (1974).
W. Löffler, W. Spann, W. Gröbner, G. Wolfram, and N. Zöllner. Normal values of uric acid in plasma and urine during ingestion of a purine-free diet. Klin Wochenschr 65 (Suppl X): 8 (1987).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
González, A.A., Puig, J.G., Mateos, F.A., Jiménez, M.L., Casas, E., Capitán, M.C. (1989). Should Dietary Restrictions Always Be Prescribed in the Treatment of Gout?. In: Mikanagi, K., Nishioka, K., Kelley, W.N. (eds) Purine and Pyrimidine Metabolism in Man VI. Advances in Experimental Medicine and Biology, vol 253A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5673-8_40
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5673-8_40
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5675-2
Online ISBN: 978-1-4684-5673-8
eBook Packages: Springer Book Archive